Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00214721 | A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis | PHASE3 | COMPLETED | 120 | — | — | Feb 1, 2005 | Jul 1, 2006 | Mar 3, 2025 | 1 | Canada |
| Name | Type | Description |
|---|---|---|
| Experimental Peritoneal Dialysis Solution | DRUG | - |
Inclusion Criteria: * Patients who have given written informed consent after the nature of the study has been explained. * Patients who are at least 18 years of age. * Patients who have been treated with CAPD using specific solutions for at least 60 days before the baseline visit. Exclusion Criter...